Clinical Trial: Study of Non-inferiority Between Manzanilla Sophia(R) and Meticel Ofteno(R) 0.5% for Providing a Relief Sensation to the Eyes.

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859476) titled 'Study of Non-inferiority Between Manzanilla Sophia(R) and Meticel Ofteno(R) 0.5% for Providing a Relief Sensation to the Eyes.' on Feb. 27.

Brief Summary: Demonstrate the non-inferiority of Manzanilla Sophia(R) compared to Meticel Ofteno(R) 0.5% in providing a sensation of eye relief, through the score of an analogous visual test for eye fatigue.

Study Start Date: Aug. 31, 2025

Study Type: INTERVENTIONAL

Condition: Ophthalmological Agent Toxicity

Intervention: DRUG: Manzanilla Sophia(R)

Manzanilla Sophia(R). Matricaria recutita 0.025%. Ophthalmic solution. Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico.

Posology...